This lesson is part of an introductory series developed by Cochrane Screening & Diagnostic Test Methods Group to support authors in the production of DTA reviews. A full list of currently available or planned lessons is available here.
This lesson explains why it is important to adequately formulate a DTA review question and defines the components of such a question. It points out that defining the clinical testing pathway is a critical component of question formulation for a test accuracy review. Finally, the lesson uses examples to illustrate how DTA review questions are transformed into DTA review title formats in Review Manager.
- Define the components of a DTA review question
- Understand what is meant by a clinical testing pathway
- Identify the standard DTA titles available for use in Review Manager
- Describe the importance of formulation of DTA review questions for other steps in a DTA review
1.4 Formulating a Cochrane DTA Review question
Cite as: Davenport CF, Leeflang MM, Takwoingi Y, Deeks JJ. Formulating a Cochrane DTA review question. Lesson 1.4: Cochrane Collaboration DTA Online Learning Materials. The Cochrane Collaboration, February 2015. Videocast (42 slides, 30 minutes, sound, colour). Available at <http://training.cochrane.org>.
Session compiled and narrated by Clare Davenport with technical support from Anne Walker and Paul Good, University of Birmingham. With grateful acknowledgement of the many members of the Cochrane DTA Reviews Working Group upon which the materials, in part, are based. Funded by the UK NIHR and the Cochrane Collaboration, with support from the University of Birmingham and the University of Amsterdam.